Publications

Dynamic regulation of alternative ATP-binding cassette transporter A1 transcripts.

Huuskonen J, Abedin M, Vishnu M, Pullinger CR, Baranzini SE, Kane JP, Fielding PE, Fielding CJ

Biochemical and biophysical research communications, 2003

Osteopontin polymorphisms and disease course in multiple sclerosis.

Caillier S, Barcellos LF, Baranzini SE, Swerdlin A, Lincoln RR, Steinman L, Martin E, Haines JL, Pericak-Vance M, Hauser SL, Oksenberg JR

Genes and immunity, 2003

Direct deletion analysis in two Duchenne muscular dystrophy symptomatic females using polymorphic dinucleotide (CA)n loci within the dystrophin gene.

Giliberto F, Ferreiro V, Dalamón V, Surace E, Cotignola J, Esperante S, Borelina D, Baranzini S, Szijan I

Journal of biochemistry and molecular biology, 2003

Pharmacogenomic analysis of interferon receptor polymorphisms in multiple sclerosis.

Sriram U, Barcellos LF, Villoslada P, Rio J, Baranzini SE, Caillier S, Stillman A, Hauser SL, Montalban X, Oksenberg JR

Genes and immunity, 2003

Large-scale gene-expression studies and the challenge of multiple sclerosis.

Baranzini SE, Hauser SL

Genome biology, 2002

The HLA locus and multiple sclerosis in Spain. Role in disease susceptibility, clinical course and response to interferon-beta.

Villoslada P, Barcellos LF, Rio J, Begovich AB, Tintore M, Sastre-Garriga J, Baranzini SE, Casquero P, Hauser SL, Montalban X, Oksenberg JR

Journal of neuroimmunology, 2002

Gene expression analysis reveals altered brain transcription of glutamate receptors and inflammatory genes in a patient with chronic focal (Rasmussen's) encephalitis.

Baranzini SE, Laxer K, Bollen A, Oksenberg JR

Journal of neuroimmunology, 2002

Analysis of antibody gene rearrangement, usage, and specificity in chronic focal encephalitis.

Baranzini SE, Laxer K, Saketkhoo R, Elkins MK, Parent JM, Mantegazza R, Oksenberg JR

Neurology, 2002

New insights into the genetics of multiple sclerosis.

Baranzini SE, Oksenberg JR, Hauser SL

Journal of rehabilitation research and development, 2002

The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease.

Chabas D, Baranzini SE, Mitchell D, Bernard CC, Rittling SR, Denhardt DT, Sobel RA, Lock C, Karpuj M, Pedotti R, Heller R, Oksenberg JR, Steinman L

Science (New York, N.Y.), 2001

Pages